Ϫ secretion in the mouse cortical collecting duct (CCD). This study's purpose was to determine the co-ion that accompanies benzamil-and DIDS-sensitive Cl Ϫ flux. Thus transepithelial voltage, VT, as well as total CO 2 (tCO2) and Cl Ϫ flux were measured in CCDs from aldosterone-treated mice consuming a NaCl-replete diet. We reasoned that if stilbene inhibitors (DIDS) reduce conductive anion secretion they should reduce the lumen-negative V T. However, during ENaC blockade (benzamil, 3 M), DIDS (100 M) application to the perfusate reduced net H ϩ secretion, which increased the lumennegative VT. Conversely, ENaC blockade alone stimulated H ϩ secretion, which reduced the lumen-negative VT. Application of an ENaC inhibitor to the perfusate reduced the lumen-negative VT, increased intercalated cell intracellular pH, and reduced net tCO 2 secretion. However, benzamil did not change tCO2 flux during apical H ϩ -ATPase blockade (bafilomycin, 5 nM). The increment in H ϩ secretion observed with benzamil application contributes to the fall in V T observed with application of this diuretic. As such, ENaC blockade reduces the lumen-negative V T by inhibiting conductive Na ϩ absorption and by stimulating H ϩ secretion by type A intercalated cells. In conclusion, 1) in CCDs from aldosterone-treated mice, benzamil application stimulates HCl secretion mediated by the apical H ϩ -ATPase and a yet to be identified conductive Cl Ϫ transport pathway; 2) benzamil-induced HCl secretion is reversed with the application of stilbene inhibitors or H ϩ -ATPase inhibitors to the perfusate; and 3) benzamil reduces VT not only by inhibiting conductive Na ϩ absorption, but also by stimulating H ϩ secretion.
chloride; H ϩ secretion; pendrin IN CORTICAL COLLECTING DUCTS (CCDs) from aldosterone-treated mice and rats, robust NaCl absorption is observed. Following epithelial Na ϩ channel (ENaC) blockade with amiloride analogs, NaCl absorption falls Ͼ50% (20, 27) Ϫ secretion, the purpose of this study was twofold: 1) to determine the coor countertransported ion that accompanies benzamil-and DIDS-sensitive Cl Ϫ transport, and 2) to determine whether inhibiting this co-or countertransport mechanism attenuates DIDS-sensitive changes in Cl Ϫ transport.
METHODS

Animals.
Unless otherwise indicated, experiments were performed in male and female wild-type mice on a 129S6/SvEv Tac background (Taconic Farms). In some experiments, male or female Slc26a4 (Ϫ/Ϫ) mice on a 129S6/SvEv Tac background, developed by Everett et al. (4) , were compared with wild-type mice from the same strain (129S6/SvEv Tac), bred in parallel. Unless otherwise stated, mice were fed a balanced diet (53881300; Zeigler Brothers) prepared as a gel (0.6% agar, 74.6% water, and 24.8% mouse chow) supplemented with NaCl (ϳ0.8 meq NaCl/day, treatment 1) and were given aldosterone by minipump (250 g·kg body wt Ϫ1 ·day Ϫ1 , treatment 2) for 5-7 days before euthanasia (11) . The Institutional Animal Care and Use Committee at Emory University approved all treatment protocols.
In vitro perfusion of isolated CCD. For transepithelial flux studies, CCDs were dissected from medullary rays and perfused at flow rates of 2-3 nl/min in the presence of a symmetric, HCO 3 Ϫ -buffered physiological solution (solution 1, Table 1 ) or in HEPES-buffered solutions (solution 2, Table 1 ). Tubules were equilibrated at 37°C for 30 min before the collections began. A stock solution of benzamil hydrochloride (3 ϫ 10 Ϫ3 M) was prepared in water. A stock solution of bafilomycin (10 Ϫ5 M) was prepared in absolute ethanol. All chemicals were purchased from Sigma-Aldrich (St. Louis, MO).
Measurement of net transepithelial Cl Ϫ flux. Cl Ϫ concentration was measured in the perfusate and collected samples using a continuous-flow fluorimeter and the Cl Ϫ -sensitive fluorophore 6 methoxy-N-(3-sulfopropyl) quinolinium (SPQ; Molecular Probes, Eugene, OR), as described previously (6, 32, 33) . Transepithelial Cl Ϫ flux, JCl, was calculated according to the equation:
where Co and CL are perfusate and collected fluid Cl Ϫ concentrations, respectively, Q is the flow rate (in nl/min), and L is tubule length. Net fluid transport was taken to be zero since net fluid flux has not been observed in CCDs when perfused in vitro in the presence of symmetric solutions and in the absence of vasopressin (12, 13) . J Cl was expressed as picomoles per millimeter per minute.
Measurement of transepithelial HCO 3 Ϫ flux, JtCO2. Total CO2 (HCO 3 Ϫ ϩH2CO3ϩCO2) concentration, which is mainly HCO 3 Ϫ in most physiological solutions, was measured in the perfusate and in collected samples using a continuous-flow fluorimeter with the method of Zhou et al. (21, 38) . Transepithelial total CO 2 flux, JtCO2, was calculated according to the equation JtCO2 ϭ (Co Ϫ CL)Q/L, where Co and CL are the ion concentrations measured in the perfusate and the collected fluid, Q is the flow rate (in nl/min), and L is the tubule length.
Measurement of transepithelial voltage. Transepithelial voltage was measured in the perfusion pipette connected to a high-impedance electrometer through an agar bridge saturated with 0.16 M NaCl and a calomel cell as described previously (29). The reference was an agar bridge from the bath to a calomel cell.
Measurement of intracellular pH. Intracellular pH was measured in intercalated cells from CCDs perfused in vitro using the esterified form of the pH-sensitive fluorophore BCECF-AM (30, 36). Tubules were mounted on concentric pipettes and then perfused in vitro for 15 min with BCECF-AM (5.4 mol/l) present in the luminal fluid (solution 1, Table 1 
RESULTS
DIDS inhibits H
ϩ secretion mediated by the H ϩ -ATPase, which increases the lumen-negative transepithelial voltage. In the companion paper (17a), we observed that ENaC inhibition stimulates conductive Cl Ϫ secretion, which is reversed with the application of stilbene inhibitors (DIDS). Further experiments examined the effect of DIDS on transepithelial voltage during ENaC inhibition. We reasoned that stimulating conductive anion secretion should increase the lumen-negative transepithelial voltage, whereas inhibiting conductive anion secretion should reduce the lumen-negative transepithelial voltage. As such, we predicted that when conductive Cl Ϫ secretion is inhibited with the nonselective Cl Ϫ transport blocker DIDS, the lumen-negative transepithelial voltage will fall, i.e., becomes less lumen negative. To test this prediction, we examined the effect of the DIDS on transepithelial voltage in CCDs from aldosterone-treated mice. Figure 1 shows that in the absence of ENaC blockade, the lumen-negative transepithelial voltage is either unchanged or slightly reduced with DIDS application (Fig. 1, A and B) , which is consistent with inhibition of a conductive Cl Ϫ secretory pathway. However, when ENaC activity is eliminated either with a chemical inhibitor (benzamil, Fig. 1C ) or with ENaC gene ablation (Fig. 1D) , DIDS application increased the lumen-negative transepithelial voltage. This DIDS-induced increase in the lumen-negative voltage observed during ENaC blockade occurred in mice given diet alone or diet and aldosterone ( Fig. 1) .
Further experiments explored the mechanism behind the unexpected rise in lumen-negative transepithelial voltage observed with stilbene inhibitor application. We hypothesized that during ENaC blockade, DIDS increases the lumen-negative transepithelial voltage by inhibiting secretion of a cation, such as H ϩ , rather than by stimulating secretion of an anion. To test this hypothesis, we examined the effect of DIDS on total CO 2 (HCO 3 Ϫ ϩCO 2 ϩH 2 CO 3 ) flux. Total CO 2 flux generally reflects HCO 3 Ϫ flux, J HCO 3 Ϫ , since total CO 2 is primarily HCO 3 Ϫ under most physiological conditions (34). Figure 2 shows that during ENaC blockade, DIDS application changed total CO 2 flux from net absorption to net total CO 2 secretion. The fall in total CO 2 absorption observed with DIDS application could be from reduced H ϩ secretion or increased secretion of OH Ϫ equivalents, such as HCO 3 Ϫ . To discriminate between these possibilities, we tested whether the DIDS-induced Figure 4 shows that in the absence of inhibitors, CCDs from aldosterone-treated mice secrete total CO 2 , as reported previously (22) . However, total CO 2 flux changed from net secretion to net absorption following benzamil application. Therefore, benzamil either stimulates H ϩ secretion or inhibits OH Ϫ secretion, such as through blockade of apical anion exchange.
To test whether ENaC blockade increases H ϩ secretion, we examined the effect of benzamil on total CO 2 flux, during apical H ϩ -ATPase blockade (bafilomycin, Fig. 4B ). As shown, blockade of the apical H ϩ -ATPase eliminated the benzamilsensitive change in total CO 2 flux. To test further whether benzamil stimulates H ϩ secretion or instead inhibits apical anion exchange, intracellular pH was measured in intercalated cells before and after the application of this diuretic to the perfusate ( Fig. 5 and Table 2 ). With Na ϩ in the luminal fluid, intercalated cell intracellular pH rose with benzamil application, consistent with stimulation of net H ϩ efflux or inhibition of OH Ϫ efflux (Fig. 5A) . In contrast, benzamil had no effect on intracellular pH in the absence of luminal Na ϩ (Fig. 5B) Figure 7 shows that benzamil reduces transepithelial voltage either in the presence (Fig. 7B) or the absence (Fig. 7A) (Fig. 8A) . However, the magnitude of benzamil-sensitive Cl 
H ϩ -ATPase inhibition blocks NKCC1-dependent Cl
Ϫ secretion. We have shown previously that the basolateral membrane Na-K-2Cl transporter NKCC1 mediates Cl Ϫ uptake across the basolateral plasma membrane of type A intercalated cells in the rat outer medullary collecting duct (OMCD) (32) and mouse CCD (20) , which is then secreted across the apical membrane into the luminal fluid (Fig. 9) . When NKCC1 is inhibited with bumetanide, Cl Ϫ secretion in the CCD is reduced (20, 32 whether apical H ϩ -ATPase blockade abolishes the effect of NKCC1 inhibitors (bumetanide) on transepithelial Cl Ϫ transport (Fig. 10) (P Ͻ 0.05), consistent with our previous observations in mouse CCD (20) . However, during blockade of both ENaC and the apical H ϩ -ATPase, Cl Ϫ absorption was unchanged with application of this NKCC1 inhibitor (Fig. 10) . We conclude that across type A intercalated cells, NKCC1 mediates Cl Ϫ uptake across the basolateral membrane. Cl Ϫ is then secreted across the type A intercalated cell apical plasma membrane through a yet to be identified apical conductive Cl Ϫ transport pathway in tandem with H ϩ secretion mediated by the apical plasma membrane H ϩ -ATPase. Model predictions of the bafilomycin-sensitive HCl secretion. In the companion study (Tables 2 and 3 in Ref. 17a) , we used a CCD model in which ClC-5 (1H ϩ /2Cl Ϫ ) is present in the type A intercalated cell luminal membrane, to simulate the effect of bafilomycin on Cl Ϫ and HCO 3 Ϫ transport. In the absence of ClC-5, the model predicts that H ϩ -ATPase inhibition will increase the lumen-negative transepithelial voltage, which should slightly increase Cl Ϫ absorption. With ClC-5 present, however, the model predicts a greater increase in Cl Ϫ absorption with bafilomycin application and predicts that bafilomycin will reduce intracellular pH within type A intercalated cells, thereby activating ClC-5-mediated Cl Ϫ absorption and H ϩ secretion. The model also predicts that in the CCD, H ϩ -ATPase inhibition will promote Cl Ϫ absorption independently of ENaC inhibition. In the absence of benzamil, the model predicts that bafilomycin will increase Cl Ϫ absorption by 9.0 pmol·mm Ϫ1 ·min Ϫ1 , due to a 10.7 pmol·mm Ϫ1 ·min
Ϫ1
increase in ClC-5-mediated Cl Ϫ flux. However, during ENaC blockade, where Cl Ϫ flux is secretory, bafilomycin should reduce this Cl Ϫ secretion by 11.5 pmol·mm Ϫ1 ·min Ϫ1 . In both cases, bafilomycin depolarizes the luminal membrane of the intercalated cell, thus providing an electrical force favoring movement of Cl Ϫ from lumen to cell. However, the model predicts a different effect of ENaC inhibition on H ϩ secretion from that observed experimentally. The model predicts that benzamil application will reduce the driving force for electrogenic H ϩ secretion by the apical membrane H ϩ -ATPase, due to the fall in lumen-negative voltage expected with the application of this diuretic. The predicted result is reduced H ϩ secretion and reduced intracellular pH within type A intercalated cells (Table 3 in 
ϩ secretion. Our experimental data show that the primary mechanism by which benzamil increases H ϩ secretion and increases intercalated cell intracellular pH is by stimulating the apical membrane H ϩ -ATPase in the type A intercalated cell. Benzamil stimulates H ϩ secretion through the apical H ϩ -ATPase, despite the fall in lumen-negative transepithelial voltage, which reduces the driving force for electrogenic H ϩ secretion. As such, this diuretic does not alter H ϩ secretion through changes in transepithelial voltage. Therefore, our observation in the companion paper (17a) that DIDSsensitive Cl Ϫ transport occurs only in the presence of benzamil is consistent with model predictions that compared total Cl Ϫ flux in the presence or absence of ClC-5. However, our observations regarding the impact of benzamil on H ϩ flux show a lack of concordance between experiment and model.
DISCUSSION
We and others have shown that inhibiting ENaC reduces Cl Ϫ absorption in CCDs from mice given aldosterone and a NaCl-replete diet (19, 20, 28) . The mechanism of benzamilsensitive Cl Ϫ absorption is thought to occur through paracel- Values are means Ϯ SE. pHi, intracellular pH. *P Ͻ 0.05, ANOVA. The apical H ϩ -ATPase generates a lumen-positive transepithelial voltage in the late distal convoluted tubule (DCT) (5) and in the OMCD (32). In the inner stripe of the OMCD, apical H ϩ and Cl Ϫ secretion are dependent on HCO 3 Ϫ /CO 2 as a H ϩ source since the lumen-positive voltage and H ϩ secretion fall markedly when HCO 3 Ϫ /CO 2 is eliminated (31, 32). Whereas HCl secretion was observed in the absence of ENaC inhibitors in the inner stripe of the OMCD from rats given an aldosterone analog (31, 32), the present study observed HCl secretion in CCDs from aldosterone-treated mice only during ENaC blockade. The HCl secretion observed in the in the inner stripe of the rat OMCD in the absence of ENaC blockade (31) may reflect the lack of net Na ϩ absorption, and presumably the lack of significant ENaC-mediated Na ϩ absorption, in this segment when perfused in vitro (25, 31).
Benzamil in the
The present study demonstrates that in the CCD, inhibiting ENaC stimulates HCl secretion that is sensitive to H ϩ -ATPase inhibitors. Our observations are consistent with those of Stoner, Burg, and Orloff (26), who showed that adding the (15, 16) showed, however, that in rabbit CCDs perfused in vitro, amiloride application to the perfusate increases net HCO 3 Ϫ secretion, or reduces net H ϩ secretion. In the turtle urinary bladder, Husted and Steinmetz (10) also observed that amiloride reduces H ϩ secretion. Because H ϩ secretion falls when the transepithelial voltage is less lumen negative (24), they concluded that amiloride reduces H ϩ secretion, in part, by hyperpolarizing the luminal membrane. However, a large increase in the lumen-negative transepithelial voltage produces only a small increment in net H ϩ secretion in the turtle bladder. As such, while the reason for the different results of the present study and those of Steinmetz is unclear, what is clear is that electrochemical driving force is not the major regulator of net H ϩ secretion along the distal nephron. The present study shows that ENaC inhibition does not stimulate H ϩ secretion through changes in driving force since ENaC inhibition increases H ϩ secretion while reducing the lumen-negative transepithelial voltage, which decreases the driving force for H ϩ secretion. ENaC inhibition may instead alter H ϩ -ATPase activity through changes in downstream luminal fluid composition or through a paracrine mechanism.
It is well established that amiloride application in vivo reduces net H ϩ excretion in the mouse, rat, and human, thereby generating a metabolic acidosis (1, 9, 23, 37). What is not clear is why amiloride analogs increase H ϩ secretion in CCDs from aldosterone-treated mice perfused in vitro, but reduce H ϩ secretion in CCDs from rabbits, at least under basal conditions (15) or following NaHCO 3 ingestion (16) . Amiloride may affect transport differently in the mouse and rabbit. Alternatively, the increase in H ϩ secretion observed during ENaC blockade may be more physiologically significant during highaldosterone states. Chronic dietary NaCl restriction increases aldosterone release, which stimulates renal Cl Ϫ transporters, such as pendrin, thereby increasing Cl Ϫ absorption. If a NaClrich meal is then consumed, serum aldosterone concentration falls, which reduces apical plasma membrane pendrin abundance probably over a period of hours to days. Without a means to rapidly reduce Na ϩ and Cl Ϫ absorption, a sudden increase in NaCl intake would markedly increase total body NaCl balance. The HCl secretion observed following ENaC blockade might represent a mechanism for rapidly reducing Cl Ϫ absorption. High NaCl intake increases distal Na ϩ delivery, which rapidly downregulates ENaC through Na ϩ selfinhibition (7). This ENaC inhibition should stimulate HCl secretion, thereby minimizing net NaCl absorption.
In the present study, benzamil did not change Cl Ϫ and H ϩ flux in a 1:1 relationship since the change in Cl Ϫ flux observed~2 (+) Fig. 9 . Proposed mechanism of benzamil-induced Cl Ϫ secretion. The Na-K2Cl cotransporter, NKCC1, mediates Cl Ϫ uptake across the basolateral membrane in type A intercalated cells. Cl Ϫ is then secreted across the apical plasma membrane through a yet to be identified pathway. H ϩ is secreted by type A cells through the apical H ϩ -ATPase, which is associated with Cl Ϫ secretion mediated by this pathway. However, there is evidence that NKCC1 localizes to the basolateral regions of not only type A intercalated cells (14, 20) , but also to the basolateral regions of principal cells (14) . 
